In 18 out of 21 samples with a known translocation, identified by either FISH or karyotyping, the breakpoints were identified by the NGS capture panel (Table 1 ). Out of the 3 samples that failed to produce results, 2 concerned fresh frozen samples from lymphomas with degraded and low-quantity DNA (<500ng total DNA and < 1kb median fragment size by TapeStation analysis) and 1 was due to a technical error due to evaporation during the hybridisation step in a BCP-ALL case.
Out of the 18 samples, 15 (83%) were from patients with B-cell LPD (BCLPD), of which 11
had well-known translocations partners: CRLF2 (2 BCP-ALL), MYC (4 Burkitt), BCL11A (1 CLL), BCL2 (2 CLL and 1 DLBCL) and CCND3 (1 SMZL). In these samples, the exact location of different breakpoints could be delineated from the sequencing reads. In addition, analysis of the reads mapping to the IGH locus showed that in 7 cases (47%) the break involved an IGHJ and/or IGHD gene whereas in 8 cases (53%) the break lay within the switch regions. The NGS capture approach thus provided additional information about the timing and aberrant cellular processes giving rise to the translocation, either occurring at the time of the D-J or V-DJ recombination or during class-switch recombination 7 . Identification of the specific breakpoint was possible in the majority of cases, although due to the high homology between the different switch regions it was not always possible to specifically map reads unequivocally.
In 3 of the 15 BCLPD samples (20%) only karyotyping results were available and the location of the breakpoint on the partner chromosome as defined by NGS was mapped to chromosomes 5q14.2 (SMZL), 1q32.1 (CLL) or 16q22.1 (CLL). However, no known lymphoma-associated genes lay in proximity to these breakpoints highlighting the potential of this approach to identify novel translocation partners and/or mechanisms of disease.
Alternatively, these chromosomal alterations may represent "passenger" recombination events, where genomic rearrangements are present in the IGH loci due to a by-product of the processing of double-stranded DNA breaks by the enzymatic machinery, not resulting in an oncogenic translocation.
In the remaining BCLPD sample -a case with DLBCL-NGS analysis was able to detect a translocation between IGH and chromosomal location 6p25. The break occurred downstream of EXOC2 and thus in the vicinity of IRF4, a constellation similar to the activating IRF4 were also identified by NGS, consistent with the clonal nature of the disorder; however, PCR and Sanger sequencing data were not available for these six cases for comparison due to insufficient DNA. This version of the EuroClonality-NGS panel did not include probes for the intron RSS or KDE sequence, explaining why the intronRSS-KDE rearrangement found
by Sanger sequencing in a Burkitt lymphoma case was not detected by the NGS approach. In two CLL cases, a total of three IGK locus gene rearrangements were detected by NGS in each case, raising the possibility of more than one clonal population being present, as previously described in chronic BCLPD 13 . Additionally, aberrant clonal rearrangements were seen that were not detected with conventional PCR based approaches (e.g. IGKV to IGK intron), which warrant further analysis. In the three TCLPD cases, Sanger sequencing identified TRDV1-TRDJ1 (T-ALL with inv (14)), a TRBV5-TRBJ1-6 (T-ALL with t(7;10)) and a TRBV5-1-TRBJ2-5 (T-NHL) rearrangements, all of which were also identified in the 
